Skip to main content
. 2023 Nov 15;15(11):6543–6550.

Table 3.

Evaluation of complications in two groups of DN patients

Complication Control group (n=60) Research group (n=66) χ2/t P
Fever 1 (1.67) 0 (0.00)
Dizziness and headache 2 (3.33) 1 (1.52)
Nausea and vomiting 1 (1.67) 1 (1.52)
Gastrointestinal reactions 2 (3.33) 2 (3.03)
Total 6 (10.00) 4 (6.06) 0.668 0.414

Note: DN, diabetic nephropathy.